Gilead Sciences Valuation Overview

GILD -- USA Stock  

USD 77.37  0.32  0.42%

Gilead Sciences retains regular Real Value of $84.54374999999999 per share. The prevalent price of the corporation is $77.37. At this time the corporation appears to be under valued. Macroaxis calculates value of Gilead Sciences from evaluating the corporation fundamentals such as Current Valuation of 104.03B, Return On Asset of 13.00% and Return On Equity of 16.76% as well as inspecting its technical indicators and Probability Of Bankruptcy. In general, we encourage to acquire undervalued assets and to sell overvalued assets since at some point stocks prices and their ongoing real values will come together.

Gilead Science took a bad hit when their bet on a medical trial failed.  Subsequently, their stock price has come down considerably. But, the company is still profitable and is very focused on growth ahead.  Also, market forces should easily push the stock price higher than where it is when looked at from a price-to-earnings ratio.  For that matter, by any matrix, the stock is cheap and should go higher.  

Valuation Drivers Correlation
Click cells to compare fundamentals   View All Correlations
Gilead Sciences Valuation Data Drivers
Net Income Per Employee    Enterprise Value    Market Capitalization    
Gilead Sciences Market Cap
Gilead Sciences is one of the top stocks in market capitalization category among related companies. Market capitalization of Pharmaceuticals And Biosciences industry is currently estimated at about 106.44 Billion. Gilead Sciences totals roughly 100.28 Billion in market capitalization claiming about 94% of equities listed under Pharmaceuticals And Biosciences industry.
Capitalization  Valuation  Total debt  Workforce  Revenue
 Time Horizon     30 Days    Login   to change
Gilead Sciences is one of the top stocks in last dividend paid category among related companies. It is one of the top stocks in price to earning category among related companies reporting about  12.86  of Price to Earning per Last Dividend Paid.

Current Market Valuation

Gilead Sciences Valuation Boundaries
Under Valued
July 23, 2018
Market Value
Real Value
Target Odds
Gilead Sciences is not too risky asset. Calculation of real value of Gilead Sciences is based on 1 month time horizon. Increasing Gilead Sciences time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.
Please also check Risk vs Return Analysis. Please also try Fundamentals Matrix module to view fundamentals matrix and analyze how accounts are interrelated and interconnected with each other.